⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for antitumor activity

Every month we try and update this database with for antitumor activity cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese SubjectsNCT01012258
Squamous Cell C...
Cetuximab + con...
18 Years - Merck KGaA, Darmstadt, Germany
An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) MutationsNCT02192697
Non-small Cell ...
ASP8273
20 Years - Astellas Pharma Inc
Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic LeukemiaNCT02316197
Advanced Solid ...
Chronic Lymphoc...
MSC2490484A (M3...
18 Years - Merck KGaA, Darmstadt, Germany
Phase I Study of TAS-106 in Combo With CarboplatinNCT00752011
Cancer
Solid Tumors
TAS-106
Carboplatin
18 Years - M.D. Anderson Cancer Center
Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese SubjectsNCT01012258
Squamous Cell C...
Cetuximab + con...
18 Years - Merck KGaA, Darmstadt, Germany
Phase I Study of TAS-106 in Combo With CarboplatinNCT00752011
Cancer
Solid Tumors
TAS-106
Carboplatin
18 Years - M.D. Anderson Cancer Center
A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid TumorsNCT01182883
Brain Stem Neop...
Glioma
Pinealoma
IMC-A12
Temsirolimus
1 Year - 21 YearsNational Institutes of Health Clinical Center (CC)
MEDI5752 in Japanese Patients With Advanced Solid Tumors.NCT05685472
Advanced Solid ...
MEDI5752
18 Years - 120 YearsAstraZeneca
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: